Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis

Autor: Zala, Vijay, De Almeida, Ana Paula, Fassoulas, Helen, Agrawal, Tanvi, Singh, Janmejay, Roy, Anjan Kumar, Berndsen, Saskia, de Mooij, Marina, Buitendijk, Hester, Stalpers, Coen, Jarju, Modou, Battistella, Filippo, Jeeninga, Rienk, Duijsings, Danny, Razzano, Ilaria, Molesti, Eleonora, Mazzini, Livia, Boccuto, Adele, Holder, Angela, Mee, Edward, Hurley, Matthew, Padley, Jennifer, Rose, Nicola, Gorman, Trina, Vila-Belda, Jose, James, Hannah, Carless, Jerome, Manak, Mark, Gagnon, Luc, Phay-Tran, Steven, Levesque-Damphousse, Philipa, Fabie, Aymeric, Daugan, Matthieu, Khan, Sarwat Tahsin, Proud, Pamela, Hussey, Bethan, Knott, Daniel, Charlton, Sue, Hallis, Bassam, Medigeshi, Guruprasad R, Garg, Neha, Anantharaj, Anbalagan, Raqib, Rubhana, Sarker, Protim, Alam, Mohammad Mamun, Rahman, Mustafizur, Murreddu, Marta, Balgobind, Angela, Hofman, Rick, Grappi, Silvia, Coluccio, Rosa, Calandro, Pierpaolo, Montomoli, Emanuele, Mattiuzzo, Giada, Prior, Sandra, Le Duff, Yann, Page, Mark, Mitchell, Jane, Schwartz, Lauren M, Bartsch, Yannic C, Azizi, Ali, Bernasconi, Valentina

Publikováno v: In The Lancet Microbe March 2024 5(3):e216-e225